These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7733147)

  • 1. Relationship of body iron status and serum aluminum in chronic renal insufficiency patients not taking any aluminum-containing drugs.
    Lin JL; Lim PS; Leu ML
    Am J Nephrol; 1995; 15(2):118-22. PubMed ID: 7733147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of body iron stores on serum aluminum level in hemodialysis patients.
    Huang JY; Huang CC; Lim PS; Wu MS; Leu ML
    Nephron; 1992; 61(2):158-62. PubMed ID: 1630539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminium-containing agents may be toxic in predialysis chronic renal insufficiency patients.
    Lin JL; Leu ML
    J Intern Med; 1996 Oct; 240(4):243-8. PubMed ID: 8918516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term low-dose aluminum-containing agents on hemoglobin synthesis in patients with chronic renal insufficiency.
    Lin JL; Kou MT; Leu ML
    Nephron; 1996; 74(1):33-8. PubMed ID: 8883017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing serum aluminum in CAPD patients.
    Montenegro J; Aguirre R; Saracho R; Moina I; Martínez I
    Clin Nephrol; 1998 Aug; 50(2):77-83. PubMed ID: 9725777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminum utensils contribute to aluminum accumulation in patients with renal disease.
    Lin JL; Yang YJ; Yang SS; Leu ML
    Am J Kidney Dis; 1997 Nov; 30(5):653-8. PubMed ID: 9370180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum aluminum transport and aluminum uptake in chronic renal failure: role of iron and aluminum metabolism.
    Cannata JB; Olaizola IR; Gomez-Alonso C; Menéndez-Fraga P; Alonso-Suarez M; Diaz-Lopez JB
    Nephron; 1993; 65(1):141-6. PubMed ID: 8413773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of iron status in patients on chronic hemodialysis: relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular volume and red cell protoporphyrin.
    Moreb J; Popovtzer MM; Friedlaender MM; Konijn AM; Hershko C
    Nephron; 1983; 35(3):196-200. PubMed ID: 6633760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ferritin in non-dialysis patients with chronic renal failure: relation to bone marrow iron stores.
    Milman N; Bangsbøll S; Pedersen NS; Visfeldt J
    Scand J Haematol; 1983 Apr; 30(4):337-44. PubMed ID: 6857149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of iron status in the response to the deferoxamine test.
    Cannata JB; Fernández-Martín JL; Díaz-López B; Alonso M; Olaizola I; Acuña G; Caramelo C; Alvarez-Grande J
    J Am Soc Nephrol; 1996 Jan; 7(1):135-9. PubMed ID: 8808120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an iron supplement on serum aluminum level and desferrioxamine mobilization test in hemodialysis patients.
    Huang JY; Wu MS; Wu CH
    Ren Fail; 2001 Nov; 23(6):789-95. PubMed ID: 11777318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin and iron.
    Sunder-Plassmann G; Hörl WH
    Clin Nephrol; 1997 Mar; 47(3):141-57. PubMed ID: 9105761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histologic features of iron-related bone disease in dialysis patients.
    McCarthy JT; Hodgson SF; Fairbanks VF; Moyer TP
    Am J Kidney Dis; 1991 May; 17(5):551-61. PubMed ID: 2024657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcium supplement preparation containing small amounts of citrate on the absorption of aluminium in normal subjects and in renal failure patients.
    Nestel AW; Meyers AM; Paiker J; Rollin HB
    Nephron; 1994; 68(2):197-201. PubMed ID: 7830856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
    Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T
    PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal aluminum excretion.
    Wilhelm M; Höhr D; Abel J; Ohnesorge FK
    Biol Trace Elem Res; 1989; 21():241-5. PubMed ID: 2484594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin resistance in iron-replete hemodialysis patients: role of aluminum toxicity.
    Tarng DC; Huang TP
    Am J Nephrol; 1998; 18(1):1-8. PubMed ID: 9481432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.